cas 913581-92-7|| where to buy 6,7-Dihydrothieno[3,2-d]pyrimidine-2,4-diol

Produktname:6,7-Dihydrothieno[3,2-d]pyrimidine-2,4-diol

IUPAC Name:6H,7H-thieno[3,2-d]pyrimidine-2,4-diol

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM151516-1g	1-2 Weeks	Ǒȯƥ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 913581-92-7 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:913581-92-7; Molekulare Formel:C6H6N2O2S; Schmelzpunkt:-; SMILES-Code:OC1=NC(O)=C2SCCC2=N1; Dichte:

: Katalognummer:CM151516; Molekulargewicht:170.19; Siedepunkt:; Mdl-Nr.:; Lagerung:Store at 2-8°C.

: Thienopyrimidines; Thienopyrimidines are a class of heterocyclic compounds with diverse biological activities depending on their detailed substitution patterns. In addition, many thienopyrimidine derivatives have shown potent activity against cancer cell lines and specific oncogenes.

: Nerandomilast; Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study.
Nerandomilast (BI 1015550) is an investigational oral, preferential inhibitor of phosphodiesterase 4B (PDE4B) that is being studied as a potential treatment for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). This compound is an investigational agent and has not been approved for use. Nerandomilast was granted FDA Breakthrough Therapy Designation for the treatment of IPF in February 2022.